Rifamycin Z, a novel ansamycin from a mutant of Nocardia mediterranea. - Suppr | 超能文献

Rifamycin Z, a novel ansamycin from a mutant of Nocardia mediterranea.

作者信息

Cricchio R, Antonini P, Ferrari P, Ripamonti A, Tuan G, Martinelli E

出版信息

J Antibiot (Tokyo). 1981 Oct;34(10):1257-60. doi: 10.7164/antibiotics.34.1257.

DOI:10.7164/antibiotics.34.1257

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Rifamycin Z, a novel ansamycin from a mutant of Nocardia mediterranea.

J Antibiot (Tokyo). 1981 Oct;34(10):1257-60. doi: 10.7164/antibiotics.34.1257.

2

Rifamycin R, a novel metabolite from a mutant of Nocardia mediterranea.利福霉素R，一种来自地中海诺卡氏菌突变体的新型代谢产物。

J Antibiot (Tokyo). 1978 Oct;31(10):949-51. doi: 10.7164/antibiotics.31.949.

3

Ansamycin biogenesis: studies on a novel rifamycin isolated from a mutant strain of Nocardia mediterranei.安莎霉素生物合成：对从地中海诺卡氏菌突变株中分离出的一种新型利福霉素的研究。

Proc Natl Acad Sci U S A. 1974 Aug;71(8):3260-4. doi: 10.1073/pnas.71.8.3260.

4

Thiazorifamycins. III. Biosynthesis of rifamycins P, Q and verde, novel metabolites from a mutant of Nocardia mediterranea.

J Antibiot (Tokyo). 1980 Aug;33(8):842-6. doi: 10.7164/antibiotics.33.842.

5

Rifamycin G, a further product of Nocardia mediterranei metabolism.利福霉素G，诺卡氏菌地中海变种代谢的又一产物。

J Antibiot (Tokyo). 1976 Apr;29(4):466-8. doi: 10.7164/antibiotics.29.466.

6

Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin I.安莎霉素生物合成的早期中间体。I. 原利福霉素I的分离与鉴定。

J Antibiot (Tokyo). 1978 Nov;31(11):1124-31. doi: 10.7164/antibiotics.31.1124.

7

A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. III. Isolation and identification of an early aromatic ansamycin-precursor containing the seven-carbon amino starter-unit and three initial acetate/propionate-units of the ansa chain.地中海诺卡氏菌中利福霉素发色团生物合成的遗传学方法。III. 一种早期芳香安莎霉素前体的分离与鉴定，该前体含有七碳氨基起始单元和安莎链的三个初始乙酸盐/丙酸盐单元。

J Antibiot (Tokyo). 1981 Jan;34(1):58-63. doi: 10.7164/antibiotics.34.58.

8

New rifamycins produced by a recombinant strain of Nocardia mediterranei.地中海诺卡氏菌重组菌株产生的新型利福霉素。

J Antibiot (Tokyo). 1981 Aug;34(8):965-70. doi: 10.7164/antibiotics.34.965.

9

B-factor, an essential regulatory substance inducing the production of rifamycin in a Nocardia sp.B因子，一种诱导诺卡氏菌属中利福霉素产生的必需调节物质。

J Antibiot (Tokyo). 1984 Dec;37(12):1587-95. doi: 10.7164/antibiotics.37.1587.

10

An Australian isolate of Nocardia mediterranea producing rifamycin SV.一株产利福霉素SV的澳大利亚地中海诺卡氏菌分离株。

J Antibiot (Tokyo). 1972 Jun;25(6):356-9. doi: 10.7164/antibiotics.25.356.

引用本文的文献

1

Looking Back to : History of the Antibiotic Discovery and Future Prospects.回首往昔：抗生素发现史与未来展望。

Antibiotics (Basel). 2021 Oct 15;10(10):1254. doi: 10.3390/antibiotics10101254.

2

Rifamycin W Analogues from S699 Δ- Strain.S699Δ 菌株来源的利福霉素 W 类似物。

Biomolecules. 2021 Jun 22;11(7):920. doi: 10.3390/biom11070920.